Relevium Technologies Inc.
|
|||
| Mailing Address: | 1000 Sherbrooke Street West Suite 2700 Montreal, Quebec H3A 3G4 |
Head Office Address: | 1000 Sherbrooke Street West Suite 2700 Montreal, Quebec H3A 3G4 |
| Contact Name: | Aurelio Useche | Principal Regulator: | Quebec |
| Business e-mail address: | auseche@releviumcorp.com | Short Form Prospectus Issuer: | No |
| Telephone Number: | 514 824-8559 | Reporting Jurisdictions: | British Columbia, Alberta, Ontario, Quebec, New Brunswick |
| Fax Number: | 514 987-1213 | Stock Exchange: | TSX Venture |
| Date of Formation: | Jul 19 2012 | Stock Symbol: | RLV |
| Jurisdiction Where Formed: | Canada | Auditor: | Ernst & Young LLP |
| Industry Classification: | consumer products - biotechnology/pharmaceuticals | General Partner: | |
| CUSIP Number: | 75942W | Transfer Agent: | Computershare Investor Services Inc. |
| Financial Year-End: | Jun 30 | Size of Issuer (Assets): | Under $5,000,000 |
|
